TY - JOUR
T1 - The expense for one implantation of a banked bone allograft from a cadaveric donor and the issues affecting current advanced medical treatment in the Japanese orthopaedic field
AU - Urabe, Ken
AU - Naruse, Kouji
AU - Uchino, Masataka
AU - Takaso, Masashi
AU - Fujita, Mamoru
AU - Uchiyama, Katsufumi
AU - Okada, Takamitsu
AU - Kasahara, Midori
AU - Itoman, Moritoshi
PY - 2009
Y1 - 2009
N2 - Demand for banked bone allografts is increasing in Japan; however, there are too few bone banks and the bone bank network is not well-established. One reason for this was lack of funding for banks. Bone banks had to bear all material expenses of banked bone allografts themselves because this was not designated a covered expense. In December 2004, the Japanese government started a new "Advanced Medical Treatment" administration system which allowed an approved institution to charge the expense of authorized advanced medical treatments directly to patients. The treatment named "Cryopreserved allogenic bone and ligamentous tissue retrieved from cadaveric donor" was approved as an advanced medical treatment in March 2007. We present the calculation method and the expense per implantation of a banked bone allograft from a cadaveric donor under this treatment and raise issues which affect this advanced medical treatment and remain to be resolved in the Japanese orthopaedic field.
AB - Demand for banked bone allografts is increasing in Japan; however, there are too few bone banks and the bone bank network is not well-established. One reason for this was lack of funding for banks. Bone banks had to bear all material expenses of banked bone allografts themselves because this was not designated a covered expense. In December 2004, the Japanese government started a new "Advanced Medical Treatment" administration system which allowed an approved institution to charge the expense of authorized advanced medical treatments directly to patients. The treatment named "Cryopreserved allogenic bone and ligamentous tissue retrieved from cadaveric donor" was approved as an advanced medical treatment in March 2007. We present the calculation method and the expense per implantation of a banked bone allograft from a cadaveric donor under this treatment and raise issues which affect this advanced medical treatment and remain to be resolved in the Japanese orthopaedic field.
UR - http://www.scopus.com/inward/record.url?scp=67651095715&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=67651095715&partnerID=8YFLogxK
U2 - 10.1007/s10561-008-9119-7
DO - 10.1007/s10561-008-9119-7
M3 - Article
C2 - 19132552
AN - SCOPUS:67651095715
SN - 1389-9333
VL - 10
SP - 259
EP - 265
JO - Cell and Tissue Banking
JF - Cell and Tissue Banking
IS - 3
ER -